Australia has announced a $1.2 billion supply and production agreement for over 84.
Oxford Biomedica announced on Monday that it has signed an 18-month supply agreement with AstraZeneca for large-scale commercial manufacturing of the adenovirus vector-based …
AstraZeneca announced that it has started enrolling adults for a Phase 3 clinical trial in the US of its Covid-19 vaccine candidate AZD1222. AstraZeneca …
AstraZeneca announced on Tuesday that it has initiated an early study trial of AZD7442, a combination of two monoclonal antibodies (mAbs), to be …
Shares in AstraZeneca are advancing in the pre-market session amid a report that the Trump administration is considering fast-tracking the drugmaker’s vaccine candidate …
UK biopharma AstraZeneca (AZN) has now received regulatory approval to hold part of a late-stage trial for its potential COVID-19 vaccine in Russia, …
AstraZeneca (AZN) has announced that its Imfinzi (durvalumab) treatment has been approved in Japan for extensive-stage small cell lung cancer (ES-SCLC), with etoposide …
The Australian government announced today that it has signed a letter of intent with UK-based drug company AstraZeneca to secure supply of the …
AstraZeneca announced on Tuesday that the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for its cancer …
AstraZeneca has reached an agreement with the European Commission (EC) to supply up to 400 million doses of its AZD1222 COVID-19 vaccine candidate. …
